Novo Nordisk A/S
NVO
$47.26
$1.292.81%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.55% | 34.97% | 0.74% | 11.77% | 19.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.55% | 34.97% | 0.74% | 11.77% | 19.05% |
| Cost of Revenue | 33.67% | 14.83% | 28.12% | 36.04% | 31.81% |
| Gross Profit | -3.70% | 38.95% | -3.75% | 7.19% | 16.78% |
| SG&A Expenses | -13.13% | -10.71% | -7.77% | 0.98% | 23.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 921.62% | 924.15% | -137.12% | -- | 105.99% |
| Total Operating Expenses | 4.33% | 3.06% | 24.74% | 18.31% | 25.63% |
| Operating Income | 0.23% | 67.30% | -18.74% | 4.52% | 11.47% |
| Income Before Tax | -20.17% | 82.74% | 4.85% | -21.11% | 40.68% |
| Income Tax Expenses | -19.06% | 85.28% | 8.57% | -17.29% | 45.74% |
| Earnings from Continuing Operations | -20.48% | 82.05% | 3.89% | -22.10% | 39.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.48% | 82.05% | 3.89% | -22.10% | 39.35% |
| EBIT | 0.23% | 67.30% | -18.74% | 4.52% | 11.47% |
| EBITDA | -0.12% | 61.50% | -16.50% | 8.23% | 16.45% |
| EPS Basic | -20.14% | 81.93% | 3.95% | -21.95% | 39.69% |
| Normalized Basic EPS | -0.95% | 82.62% | -11.02% | 8.69% | 15.12% |
| EPS Diluted | -20.28% | 81.87% | 3.99% | -21.83% | 39.93% |
| Normalized Diluted EPS | -1.12% | 82.65% | -10.95% | 8.82% | 15.32% |
| Average Basic Shares Outstanding | -0.42% | 0.07% | -0.06% | -0.20% | -0.24% |
| Average Diluted Shares Outstanding | -0.25% | 0.05% | -0.14% | -0.31% | -0.42% |
| Dividend Per Share | 0.42% | -- | 9.75% | -- | 12.95% |
| Payout Ratio | -- | -0.40% | -- | 0.46% | -- |